SKI-606, a Src/Abl Inhibitor with In vivo Activity in Colon Tumor Xenograft Models

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

Druker, B. J., Tamura, S., Buchdunger, E., Ohno-Jones, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 3,618 · see citing works

Focal adhesion kinase: the first ten years

Parsons, J. T. (2003) · Journal of Cell Science · doi:10.1242/jcs.00373 · Cited by 1,364 · see citing works

Src family kinases in tumor progression and metastasis

Summy, J. M., & Gallick, G. E. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023772912750 · Cited by 827 · see citing works

Src in cancer: deregulation and consequences for cell behaviour

Frame, M. C. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00040-9 · Cited by 682 · see citing works

Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis

Weis, S. M., Cui, J., Barnes, L. A., & Cheresh, D. A. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200408130 · Cited by 477 · see citing works

Evidence for In Vivo Phosphorylation of the Grb2 SH2-Domain Binding Site on Focal Adhesion Kinase by Src-Family Protein-Tyrosine Kinases

Schlaepfer, D. D., & Hunter, T. R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5623 · Cited by 461 · see citing works

SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice.

Golas, J. M., Arndt, K. T., Etienne, C., Lucas, J., Nardin, D., Gibbons, J. J., Frost, P., Ye, F., Boschelli, D. H., & Boschelli, F. (2003) · PubMed · Cited by 412 · see citing works

Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer.

Talamonti, M. S., Roh, M. S., Curley, S. A., & Gallick, G. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116200 · Cited by 399 · see citing works

Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling

Avizienyte, E., Wyke, A. W., Jones, R. J., McLean, G. W., Westhoff, M., Brunton, V. G., & Frame, M. C. (2002) · Nature Cell Biology · doi:10.1038/ncb829 · Cited by 359 · see citing works

Src-mediated coupling of focal adhesion kinase to integrin αvβ5 in vascular endothelial growth factor signaling

Eliceiri, B. P., Puente, X. S., Hood, J. D., Stupack, D. G., Schlaepfer, D. D., Huang, X., Sheppard, D., & Cheresh, D. A. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200109079 · Cited by 333 · see citing works

The epidermal growth factor receptor–tyrosine kinase: A promising therapeutic target in solid tumors

Ritter, C. A., & Arteaga, C. L. (2003) · Seminars in Oncology · doi:10.1053/sonc.2003.50027 · Cited by 312 · see citing works

Activation of Src kinase in primary colorectal carcinoma: An indicator of poor clinical prognosis

Allgayer, H., Boyd, D. D., Heiss, M. M., Abdalla, E. K., Curley, S. A., & Gallick, G. E. (2002) · Cancer · doi:10.1002/cncr.10221 · Cited by 251 · see citing works

Overexpression and Activation of the Tyrosine Kinase Src in Human Pancreatic Carcinoma

Lutz, M. P., Eßer, I. B. S., Flossmann-Kast, B. B. M., Vogelmann, R., Lührs, H., Friess, H., Büchler, M. W., & Adler, G. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.8043 · Cited by 248 · see citing works

The mechanisms of action of rituximab in the elimination of tumor cells

Johnson, P., & Glennie, M. J. (2003) · Seminars in Oncology · doi:10.1053/sonc.2003.50025 · Cited by 247 · see citing works

Focal Adhesion Kinase Tyrosine-861 Is a Major Site of Phosphorylation by Src

Calalb, M. B., Zhang, X., Polte, T. R., & Hanks, S. K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1714 · Cited by 223 · see citing works

Optimization of 4-Phenylamino-3-quinolinecarbonitriles as Potent Inhibitors of Src Kinase Activity

Boschelli, D. H., Ye, F., Wang, Y. D., Dutia, M. D., Johnson, S. L., Wu, B., Miller, K., Powell, D. W., Yaczko, D., Young, M., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0102250 · Cited by 218 · see citing works

Src activation regulates anoikis in human colon tumor cell lines

Windham, T. C., Parikh, N. U., Siwak, D. R., Summy, J. M., McConkey, D. J., Kraker, A. J., & Gallick, G. E. (2002) · Oncogene · doi:10.1038/sj.onc.1205989 · Cited by 216 · see citing works

Down-regulation of Vascular Endothelial Growth Factor in a Human Colon Carcinoma Cell Line Transfected with an Antisense Expression Vector Specific for c-src

Ellis, L. M., Staley, C. A., Liu, W., Fleming, R., Parikh, N. U., Bucana, C. D., & Gallick, G. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.2.1052 · Cited by 200 · see citing works

Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells

Slack, J. K., Adams, R. B., Rovin, J. D., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204208 · Cited by 199 · see citing works

Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells

ABU-GHAZALEH, R., Kabir, J., Jia, H., Mel, L. O. B. O., & Zachary, I. C. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3600255 · Cited by 197 · see citing works

Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells

Duxbury, M. S., Ito, H., Zinner, M. J., Ashley, S. W., & Whang, E. E. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1183-3 · Cited by 192 · see citing works

Activated Src Protein Tyrosine Kinase Is Overexpressed in Late-Stage Human Ovarian Cancers

Wiener, J. R., Windham, T. C., Estrella, V. C., Parikh, N. U., Thall, P. F., Deavers, M. T., Bast, R. C., Mills, G. B., & Gallick, G. E. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6851 · Cited by 175 · see citing works

Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis.

Nam, J., Ino, Y., Sakamoto, M., & Hirohashi, S. (2002) · PubMed · Cited by 175 · see citing works

The Catalytic Activity of the Src Family Kinases Is Required to Disrupt Cadherin-dependent Cell–Cell Contacts

Owens, D. W., McLean, G. W., Wyke, A. W., Paraskeva, C., Parkinson, E. K., Frame, M. C., & Brunton, V. G. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.1.51 · Cited by 158 · see citing works

Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells

ABU-GHAZALEH, R., Kabir, J., Jia, H., et al. (2001) · Biochemical Journal · doi:10.1042/bj3600255 · Cited by 141 · see citing works

Biochemical and cellular effects of c-Src kinase-selective pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors

Kraker, A. J., Hartl, B. G., Amar, A. M., Barvian, M. R., Showalter, H. D., & Moore, C. W. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00405-6 · Cited by 140 · see citing works

The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy.

Attoub, S., Rivat, C., Rodrigues, S., et al. (2002) · PubMed · Cited by 136 · see citing works

Inhibition of Src Tyrosine Kinase as Treatment for Human Pancreatic Cancer Growing Orthotopically in Nude Mice

Yezhelyev, M., Koehl, G. E., Guba, M. O., Brabletz, T., Jauch, K., Ryan, A. J., Barge, A., Green, T., Fennell, M., & Bruns, C. J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0621 · Cited by 134 · see citing works

2-Substituted Aminopyrido[2,3-d]pyrimidin-7(8H)-ones. Structure−Activity Relationships Against Selected Tyrosine Kinases and in Vitro and in Vivo Anticancer Activity

Klutchko, S. R., Hamby, J. M., Boschelli, D. H., Wu, Z., Kraker, A. J., Amar, A. M., Hartl, B. G., Shen, C., Klohs, W. D., Steinkampf, R. W., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9802259 · Cited by 130 · see citing works

Increased Src activity disrupts cadherin/catenin-mediated homotypic adhesion in human colon cancer and transformed rodent cells.

Irby, R., & Yeatman, T. J. (2002) · PubMed · Cited by 123 · see citing works

Site-Specific Differences in pp60c-src Activity in Human Colorectal Metastases

Termuhlen, P. M., Curley, S. A., Talamonti, M. S., Saboorian, M. H., & Gallick, G. E. (1993) · Journal of Surgical Research · doi:10.1006/jsre.1993.1046 · Cited by 108 · see citing works

Src Family Kinases: Potential Targets for the Treatment of Human Cancer and Leukemia

Warmuth, M., Damoiseaux, R. D., Liu, Y., Fabbro, D., & Gray, N. S. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454126 · Cited by 108 · see citing works

Src tyrosine kinase promotes survival and resistance to chemotherapeutics in a mouse ovarian cancer cell line

Pengetnze, Y., Steed, M., Roby, K. F., Terranova, P. F., & Taylor, C. C. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.012 · Cited by 107 · see citing works

Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and -independent growth of human tumor cells.

Laird, A., Li, G., Moss, K. G., Blake, R. A., Broome, M. A., Cherrington, J. M., & Mendel, D. B. (2003) · PubMed · Cited by 101 · see citing works

Src Kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells

Chou, M. T.-H., Wang, J., & Fujita, D. J. (2002) · BMC Biochemistry · doi:10.1186/1471-2091-3-32 · Cited by 98 · see citing works

Studies with ZD1839 in preclinical models

Sirotnak, F. M. (2003) · Seminars in Oncology · doi:10.1053/sonc.2003.50028 · Cited by 92 · see citing works

Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis

Wei, L., Yu, Y., Zhang, X., & Yu, Q. (2004) · Oncogene · doi:10.1038/sj.onc.1208091 · Cited by 91 · see citing works

Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model.

Wiener, J. R., Nakano, K., Kruzelock, R. P., Bucana, C. D., Bast, R. C., & Gallick, G. E. (1999) · PubMed · Cited by 91 · see citing works

Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src.

Staley, C. A., Parikh, N. U., & Gallick, G. E. (1997) · PubMed · Cited by 90 · see citing works

Tyrosine Phosphorylation of Focal Adhesion Kinase Stimulated by Hepatocyte Growth Factor Leads to Mitogen-activated Protein Kinase Activation

Chen, H.-C., Chan, P.-C., Tang, M., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25777 · Cited by 86 · see citing works

Inhibition of tyrosine kinase Src suppresses pancreatic cancer invasiveness

Ito, H., Gardner-Thorpe, J., Zinner, M. J., et al. (2003) · Surgery · doi:10.1067/msy.2003.224 · Cited by 80 · see citing works

Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro

Recchia, I., Rucci, N., Festuccia, C., Bologna, M., Mackay, A. R., Migliaccio, S., Longo, M., Šuša, M., Fabbro, D., & Teti, A. M. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00394-0 · Cited by 76 · see citing works

Activity of pp60c-src in 60 different cell lines derived from human tumors.

Budde, R. J. A., Ke, S., & Levin, V. A. (1994) · PubMed · Cited by 76 · see citing works

Coexpression of IGF-1R and c-Src Proteins in Human Pancreatic Ductal Adenocarcinoma

Hakam, A., Fang, Q., Karl, R. C., & Coppola, D. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1026122421369 · Cited by 75 · see citing works

7-Alkoxy-4-phenylamino-3-quinolinecar-bonitriles as Dual Inhibitors of Src and Abl Kinases

Boschelli, D. H., Wang, Y. D., Johnson, S., Wu, B., Ye, F., Sosa, A. C. B., Golas, J. M., & Boschelli, F. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0499458 · Cited by 74 · see citing works

Transforming Growth Factor-β1-dependent Urokinase Up-regulation and Promotion of Invasion Are Involved in Src-MAPK-dependent Signaling in Human Ovarian Cancer Cells

Tanaka, Y., Kobayashi, H., Suzuki, M., Kanayama, N., & Terao, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309131200 · Cited by 74 · see citing works

Augmentation of metalloproteinase (gelatinase) activity secreted from Rous sarcoma virus-infected cells correlates with transforming activity of src.

Hamaguchi, M., Yamagata, S., Thant, A. A., et al. (1995) · PubMed · Cited by 54 · see citing works

Soluble 2-Substituted Aminopyrido[2,3-d]pyrimidin-7-yl Ureas. Structure−Activity Relationships against Selected Tyrosine Kinases and Exploration of in Vitro and in Vivo Anticancer Activity

Schroeder, M. C., Hamby, J. M., Connolly, C. J. C., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0004291 · Cited by 53 · see citing works

Intestinal HT-29 cells with dysfunction of E-cadherin show increased pp60src activity and tyrosine phosphorylation of p120-catenin

Skoudy, A., Llosas, M. D. M., & de Herreros, A. G. (1996) · Biochemical Journal · doi:10.1042/bj3170279 · Cited by 52 · see citing works

Novel bone-targeted Src tyrosine kinase inhibitor drug discovery.

Shakespeare, W. C., Metcalf, C. A., Wang, Y., Sundaramoorthi, R., Keenan, T. P., Weigele, M., Bohacek, R. S., Dalgarno, D. C., & Sawyer, T. K. (2003) · PubMed · Cited by 41 · see citing works

Phosphorylation of a Src Kinase at the Autophosphorylation Site in the Absence of Src Kinase Activity

Chiang, G. G., & Sefton, B. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6055 · Cited by 40 · see citing works

The effect of dibutyryl camp (dBcAMP) on morphological differentiation, growth and invasion in vitro of a hamster brain‐tumor cell line: A comparative study of dBcAMP effects in 2‐ and 3‐dimensional cultures

Boghaert, E. R., Simpson, J. E., Jacob, R. J., et al. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910470422 · Cited by 15 · see citing works

ChemInform Abstract: 2‐Substituted Aminopyrido[2,3‐d]pyrimidin‐7(8H)‐ones. Structure—Activity Relationships Against Selected Tyrosine Kinases and in vitro and in vivo Anticancer Activity.

Klutchko, S. R., & AL., E. A. E. (1998) · ChemInform · doi:10.1002/chin.199849199 · Cited by 2 · see citing works

Src kinases as therapeutic targets for cancer

Kim, L. C., Song, L., & Haura, E. B. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.129 · Cited by 700 · see citing works

Current status of SRC inhibitors in solid tumor malignancies

Puls, L. N., Eadens, M., & Messersmith, W. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0408 · Cited by 158 · see citing works

Src continues aging: current and future clinical directions

Kopetz, S., Shah, A. N., & Gallick, G. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1902 · Cited by 111 · see citing works

Regulation of Src Family Kinases during Colorectal Cancer Development and Its Clinical Implications

Jin, W. (2020) · Cancers · doi:10.3390/cancers12051339 · Cited by 86 · see citing works

Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium

Sharma, M. R., Wroblewski, K., Polite, B. N., Knost, J. A., Wallace, J. A., Modi, S., Sleckman, B. G., Taber, D., Vokes, E. E., Stadler, W. M., et al. (2012) · Investigational New Drugs · doi:10.1007/s10637-011-9681-x · Cited by 49 · see citing works

The molecular rationale of Src inhibition in colorectal carcinomas

Gargalionis, A. N., Karamouzis, M. V., & Papavassiliou, A. G. (2014) · International Journal of Cancer · doi:10.1002/ijc.28299 · Cited by 47 · see citing works

Analysis of SRC Oncogenic Signaling in Colorectal Cancer by Stable Isotope Labeling with Heavy Amino Acids in Mouse Xenografts

Sirvent, A., Vigy, O., Orsetti, B., Urbach, S., & Roche, S. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.018168 · Cited by 33 · see citing works

Dasatinib Is Preclinically Active against Src-Overexpressing Human Transitional Cell Carcinoma of the Urothelium with Activated Src Signaling

Levitt, J. M., Yamashita, H., Jian, W., Lerner, S. P., & Sonpavde, G. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0096 · Cited by 37 · see citing works

c-Abl Has High Intrinsic Tyrosine Kinase Activity That Is Stimulated by Mutation of the Src Homology 3 Domain and by Autophosphorylation at Two Distinct Regulatory Tyrosines

Brasher, B. B., & Etten, R. A. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005401200 · Cited by 278 · see citing works

Src homology domains of v-Src stabilize an active conformation of the tyrosine kinase catalytic domain

Xu, B., & Miller, W. T. (1996) · Molecular and Cellular Biochemistry · doi:10.1007/bf00225883 · Cited by 20 · see citing works

Src activation and translocation from focal adhesions to membrane ruffles contribute to formation of new adhesion sites

Hamadi, A., Deramaudt, T. B., Takeda, K., & Rondé, P. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8424-4 · Cited by 26 · see citing works

Src kinase inhibitors for the treatment of sarcomas: Cellular and molecular mechanisms of action

Shor, A. C. (2007) · Digital Commons - University of South Florida (University of South Florida) · Cited by 2 · see citing works